• レポートコード:QYR2104Z5471 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、94ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、スタージーウェーバー症候群(SWS)治療のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(投薬、レーザー治療、手術処置)、用途別市場規模(病院、診療所、診断センター、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・スタージーウェーバー症候群(SWS)治療の市場動向 ・企業の競争状況、市場シェア ・スタージーウェーバー症候群(SWS)治療の種類別市場規模(投薬、レーザー治療、手術処置) ・スタージーウェーバー症候群(SWS)治療の用途別市場規模(病院、診療所、診断センター、その他) ・スタージーウェーバー症候群(SWS)治療の北米市場規模2016-2027(アメリカ、カナダ) ・スタージーウェーバー症候群(SWS)治療のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・スタージーウェーバー症候群(SWS)治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・スタージーウェーバー症候群(SWS)治療の中南米市場規模2016-2027(メキシコ、ブラジル) ・スタージーウェーバー症候群(SWS)治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Abbott、Pfizer、Roche、Novartis、Johnson & Johnson、UCB、Sanofi、Takeda、Aleva Neurotherapeutics、GW Pharmaceuticals、ElectroCore) ・結論 |
Sturge-Weber syndrome or Sturge-Weber-Krabbe disease, sometimes referred to as encephalotrigeminal angiomatosis, is a rare congenital neurological and skin disorder. It is one of the phakomatoses and is often associated with port-wine stains of the face, glaucoma, seizures, mental retardation, and ipsilateral leptomeningeal angioma (cerebral malformations and tumors).
Market Analysis and Insights: Global Sturge Weber Syndrome (SWS) Treatment Market
The global Sturge Weber Syndrome (SWS) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sturge Weber Syndrome (SWS) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sturge Weber Syndrome (SWS) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sturge Weber Syndrome (SWS) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sturge Weber Syndrome (SWS) Treatment market.
Global Sturge Weber Syndrome (SWS) Treatment Scope and Market Size
Sturge Weber Syndrome (SWS) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sturge Weber Syndrome (SWS) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medication
Laser Therapy
Surgical Procedures
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Pfizer
Roche
Novartis
Johnson & Johnson
UCB
Sanofi
Takeda
Aleva Neurotherapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sturge Weber Syndrome (SWS) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Laser Therapy
1.2.4 Surgical Procedures
1.3 Market by Application
1.3.1 Global Sturge Weber Syndrome (SWS) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sturge Weber Syndrome (SWS) Treatment Market Perspective (2016-2027)
2.2 Sturge Weber Syndrome (SWS) Treatment Growth Trends by Regions
2.2.1 Sturge Weber Syndrome (SWS) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sturge Weber Syndrome (SWS) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Sturge Weber Syndrome (SWS) Treatment Industry Dynamic
2.3.1 Sturge Weber Syndrome (SWS) Treatment Market Trends
2.3.2 Sturge Weber Syndrome (SWS) Treatment Market Drivers
2.3.3 Sturge Weber Syndrome (SWS) Treatment Market Challenges
2.3.4 Sturge Weber Syndrome (SWS) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sturge Weber Syndrome (SWS) Treatment Players by Revenue
3.1.1 Global Top Sturge Weber Syndrome (SWS) Treatment Players by Revenue (2016-2021)
3.1.2 Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Sturge Weber Syndrome (SWS) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sturge Weber Syndrome (SWS) Treatment Revenue
3.4 Global Sturge Weber Syndrome (SWS) Treatment Market Concentration Ratio
3.4.1 Global Sturge Weber Syndrome (SWS) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sturge Weber Syndrome (SWS) Treatment Revenue in 2020
3.5 Sturge Weber Syndrome (SWS) Treatment Key Players Head office and Area Served
3.6 Key Players Sturge Weber Syndrome (SWS) Treatment Product Solution and Service
3.7 Date of Enter into Sturge Weber Syndrome (SWS) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sturge Weber Syndrome (SWS) Treatment Breakdown Data by Type
4.1 Global Sturge Weber Syndrome (SWS) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Type (2022-2027)
5 Sturge Weber Syndrome (SWS) Treatment Breakdown Data by Application
5.1 Global Sturge Weber Syndrome (SWS) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sturge Weber Syndrome (SWS) Treatment Market Size (2016-2027)
6.2 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Type
6.2.1 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021)
6.2.2 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2022-2027)
6.2.3 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2027)
6.3 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Application
6.3.1 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2021)
6.3.2 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2022-2027)
6.3.3 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2027)
6.4 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Country
6.4.1 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2016-2021)
6.4.2 North America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Sturge Weber Syndrome (SWS) Treatment Market Size (2016-2027)
7.2 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Type
7.2.1 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2027)
7.3 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Application
7.3.1 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2027)
7.4 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Country
7.4.1 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Type
8.2.1 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Application
8.3.1 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Region
8.4.1 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size (2016-2027)
9.2 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Type
9.2.1 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2027)
9.3 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Application
9.3.1 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2027)
9.4 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Country
9.4.1 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Type
10.2.1 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Application
10.3.1 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Country
10.4.1 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Sturge Weber Syndrome (SWS) Treatment Introduction
11.1.4 Abbott Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Sturge Weber Syndrome (SWS) Treatment Introduction
11.2.4 Pfizer Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Sturge Weber Syndrome (SWS) Treatment Introduction
11.3.4 Roche Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Sturge Weber Syndrome (SWS) Treatment Introduction
11.4.4 Novartis Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Sturge Weber Syndrome (SWS) Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 UCB
11.6.1 UCB Company Details
11.6.2 UCB Business Overview
11.6.3 UCB Sturge Weber Syndrome (SWS) Treatment Introduction
11.6.4 UCB Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.6.5 UCB Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Sturge Weber Syndrome (SWS) Treatment Introduction
11.7.4 Sanofi Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Sturge Weber Syndrome (SWS) Treatment Introduction
11.8.4 Takeda Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.8.5 Takeda Recent Development
11.9 Aleva Neurotherapeutics
11.9.1 Aleva Neurotherapeutics Company Details
11.9.2 Aleva Neurotherapeutics Business Overview
11.9.3 Aleva Neurotherapeutics Sturge Weber Syndrome (SWS) Treatment Introduction
11.9.4 Aleva Neurotherapeutics Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.9.5 Aleva Neurotherapeutics Recent Development
11.10 GW Pharmaceuticals
11.10.1 GW Pharmaceuticals Company Details
11.10.2 GW Pharmaceuticals Business Overview
11.10.3 GW Pharmaceuticals Sturge Weber Syndrome (SWS) Treatment Introduction
11.10.4 GW Pharmaceuticals Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.10.5 GW Pharmaceuticals Recent Development
11.11 ElectroCore
11.11.1 ElectroCore Company Details
11.11.2 ElectroCore Business Overview
11.11.3 ElectroCore Sturge Weber Syndrome (SWS) Treatment Introduction
11.11.4 ElectroCore Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
11.11.5 ElectroCore Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Sturge Weber Syndrome (SWS) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Laser Therapy
Table 4. Key Players of Surgical Procedures
Table 5. Global Sturge Weber Syndrome (SWS) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sturge Weber Syndrome (SWS) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Sturge Weber Syndrome (SWS) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Regions (2016-2021)
Table 9. Global Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Regions (2022-2027)
Table 11. Sturge Weber Syndrome (SWS) Treatment Market Trends
Table 12. Sturge Weber Syndrome (SWS) Treatment Market Drivers
Table 13. Sturge Weber Syndrome (SWS) Treatment Market Challenges
Table 14. Sturge Weber Syndrome (SWS) Treatment Market Restraints
Table 15. Global Sturge Weber Syndrome (SWS) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Players (2016-2021)
Table 17. Global Top Sturge Weber Syndrome (SWS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sturge Weber Syndrome (SWS) Treatment as of 2020)
Table 18. Ranking of Global Top Sturge Weber Syndrome (SWS) Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Sturge Weber Syndrome (SWS) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sturge Weber Syndrome (SWS) Treatment Product Solution and Service
Table 22. Date of Enter into Sturge Weber Syndrome (SWS) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Sturge Weber Syndrome (SWS) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Sturge Weber Syndrome (SWS) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Sturge Weber Syndrome (SWS) Treatment Product
Table 65. Abbott Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Sturge Weber Syndrome (SWS) Treatment Product
Table 70. Pfizer Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Sturge Weber Syndrome (SWS) Treatment Product
Table 75. Roche Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Sturge Weber Syndrome (SWS) Treatment Product
Table 80. Novartis Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Sturge Weber Syndrome (SWS) Treatment Product
Table 85. Johnson & Johnson Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. UCB Company Details
Table 88. UCB Business Overview
Table 89. UCB Sturge Weber Syndrome (SWS) Treatment Product
Table 90. UCB Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 91. UCB Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Sturge Weber Syndrome (SWS) Treatment Product
Table 95. Sanofi Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. Takeda Company Details
Table 98. Takeda Business Overview
Table 99. Takeda Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 100. Takeda Recent Development
Table 101. Aleva Neurotherapeutics Company Details
Table 102. Aleva Neurotherapeutics Business Overview
Table 103. Aleva Neurotherapeutics Sturge Weber Syndrome (SWS) Treatment Product
Table 104. Aleva Neurotherapeutics Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 105. Aleva Neurotherapeutics Recent Development
Table 106. GW Pharmaceuticals Company Details
Table 107. GW Pharmaceuticals Business Overview
Table 108. GW Pharmaceuticals Sturge Weber Syndrome (SWS) Treatment Product
Table 109. GW Pharmaceuticals Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 110. GW Pharmaceuticals Recent Development
Table 111. ElectroCore Company Details
Table 112. ElectroCore Business Overview
Table 113. ElectroCore Sturge Weber Syndrome (SWS) Treatment Product
Table 114. ElectroCore Revenue in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021) & (US$ Million)
Table 115. ElectroCore Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Laser Therapy Features
Figure 4. Surgical Procedures Features
Figure 5. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Sturge Weber Syndrome (SWS) Treatment Report Years Considered
Figure 11. Global Sturge Weber Syndrome (SWS) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Sturge Weber Syndrome (SWS) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Regions (2022-2027)
Figure 15. Global Sturge Weber Syndrome (SWS) Treatment Market Share by Players in 2020
Figure 16. Global Top Sturge Weber Syndrome (SWS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sturge Weber Syndrome (SWS) Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Sturge Weber Syndrome (SWS) Treatment Revenue in 2020
Figure 18. Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Sturge Weber Syndrome (SWS) Treatment Market Share by Type (2016-2027)
Figure 22. North America Sturge Weber Syndrome (SWS) Treatment Market Share by Application (2016-2027)
Figure 23. North America Sturge Weber Syndrome (SWS) Treatment Market Share by Country (2016-2027)
Figure 24. United States Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Sturge Weber Syndrome (SWS) Treatment Market Share by Type (2016-2027)
Figure 28. Europe Sturge Weber Syndrome (SWS) Treatment Market Share by Application (2016-2027)
Figure 29. Europe Sturge Weber Syndrome (SWS) Treatment Market Share by Country (2016-2027)
Figure 30. Germany Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Sturge Weber Syndrome (SWS) Treatment Market Share by Region (2016-2027)
Figure 40. China Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Sturge Weber Syndrome (SWS) Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Sturge Weber Syndrome (SWS) Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Sturge Weber Syndrome (SWS) Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Sturge Weber Syndrome (SWS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 64. UCB Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 67. Aleva Neurotherapeutics Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 68. GW Pharmaceuticals Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 69. ElectroCore Revenue Growth Rate in Sturge Weber Syndrome (SWS) Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed